Esophageal cancer secondary prevention
|
Esophageal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Esophageal cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Esophageal cancer secondary prevention |
|
Risk calculators and risk factors for Esophageal cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Secondary prevention may be effective in reducing the incidence of esophageal cancer, if treated early at the dysplasia stage with monoclonal antibody therapy. At present, there is no particular program in place to reduce the incidence of esophageal cancer.
Secondary Prevention
- Secondary prevention can be effective in high risk groups whom frequently smoke and drink alcohol if they are treated early enough in the dysplastic phase before cancer occurs.[1]
- A study was carried out in Hishun village, China.
- Due to different dietary factors, the incidence of esophageal cancer amongst these people was particularly high.
- Subjects were examined by esophageal exfoliative cytology.
- One third of the participants had marked dysplasia.
- They were placed on a antitumor B regimen for 3 years.
- The incidence of esophageal cancer in the antitumor B group was reduced by 53%.
- These results demonstrated the effectiveness of secondary prevention in the prevention of esophageal cancer.
- A study was carried out in Hishun village, China.